IXAZOMIB Pharmacologic Class Indexing

Class set ID
d0f86c40-7701-4d7d-bccf-6a88e6994b6c
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 2015Takeda Pharmaceuticals America, Inc. | Eurofins Lancaster Laboratories, Inc | AndersonBrecon (UK) Limited | Eurofins Biopharma Product Testing Ireland Limited | Almac Sciences Limited2025081816